Contact
 

The Keystone Symposium on HIV Vaccines: Adaptive Immunity and Beyond was held in Banff, Canada on 9-14 March, 2014.  The meeting’s main focus was the coordinated action of the humoral, cellular, and innate arms of the immune system...

In January 2013, the Enterprise held a consultation in Uganda on conducting efficacy trials of HIV prevention approaches in infants born to HIV-positive mothers in resource-limited settings (see the full report at...

In the field of HIV vaccines, the prevention of HIV through mucosal infection has emerged as a critical area for investigation.  Mucosal surfaces, such as vaginal and rectal surfaces, are primary sites of HIV infection and offer potentially...

Highlights from the 31st Annual Symposium on Nonhuman Primate Models for AIDS held on 3–6 November 2013, in Atlanta, Georgia (www.yerkes.emory.edu/aidsconf/)...

AIDS Vaccine 2013 was hosted by the Global HIV Vaccine Enterprise together with the Catalan Program for HIV Vaccine Research (HIVACAT) at the Barcelona International Convention Center from 7 – 10 October.  More than 900 researchers, funders...

The Enterprise held a webinar to share highlights from the recent thinktank on antibody durability, http://www.vaccineenterprise.org/timely-...

The Enterprise together with AVAC, the Bill & Melinda Gates Foundation and the Treatment Action Group (TAG) hosted a consultation in September on strategic directions for therapeutic vaccines research.  Join us on Monday, 18 November at...

The Enterprise held a webinar on the challenges facing researchers who want to advance their vaccine candidate from preclinical studies to a first-in-human trial. The webinar introduced a new interactive webtool designed to help researchers...

AIDS Vaccine 2013 welcomed more than 900 of the world's leading vaccine researchers, funders and policy makers to Barcelona, Spain for four days of exchange, debate and direction-setting for the field. Check out the conference webcasts,...

Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account